Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Rose Beck"'
Autor:
Kevin Kalisz, Francesco Alessandrino, Rose Beck, Daniel Smith, Elias Kikano, Nikhil H. Ramaiya, Sree Harsha Tirumani
Publikováno v:
Insights into Imaging, Vol 10, Iss 1, Pp 1-16 (2019)
Abstract Burkitt lymphoma (BL) is a highly aggressive, rapidly growing B cell non-Hodgkin lymphoma, which manifests in several subtypes including sporadic, endemic, and immunodeficiency-associated forms. Pathologically, BL is classically characterize
Externí odkaz:
https://doaj.org/article/40a7c2c0abd644f9b96f2ea89d9bb52d
Autor:
Keman Zhang, Nand K Roy, Yorleny Vicioso, Janghee Woo, Rose Beck, Marcos de Lima, Paolo Caimi, Daniel Feinberg, Reshmi Parameswaran
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Mantle cell lymphoma (MCL) is an aggressive form of B cell non-Hodgkin’s lymphoma and remains incurable under current treatment modalities. One of the main reasons for treatment failure is the development of drug resistance. Accumulating evidence s
Externí odkaz:
https://doaj.org/article/58a0466b9ab34a34b3743a61c48c7199
Figure 6S from Combination Therapy for Treating Advanced Drug-Resistant Acute Lymphoblastic Leukemia
Autor:
Reshmi Parameswaran, John Letterio, Derek P. Wong, Keman Zhang, Abhishek Asthana, Rose Beck, Hermann Gram, Yorleny Vicioso
Supp. Fig. 6 EW-7197 treatment increases VAY736 induced NK cell mediated ADCC of ALL cells in vivo A, Percentages of CD16+ NK cells in bone marrow and spleen of mice from Figure.6C-E. B, Normalized weight in grams (spleen weight/mouse weight) and rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ea84e9801601107020ae103350c5353
https://doi.org/10.1158/2326-6066.22542562
https://doi.org/10.1158/2326-6066.22542562
Figure 5S from Combination Therapy for Treating Advanced Drug-Resistant Acute Lymphoblastic Leukemia
Autor:
Reshmi Parameswaran, John Letterio, Derek P. Wong, Keman Zhang, Abhishek Asthana, Rose Beck, Hermann Gram, Yorleny Vicioso
Supp. Fig. 5 EW-7197 treatment increases VAY736 induced NK cell mediated ADCC of ALL cells in vivo A, Mouse TGF-beta Elisa using serum from PBS or ALL (PT-3) i.v. injected mice on day 35. B, Normalized weight (spleen weight/mouse weight) and represen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::713f80dde2536288c31e94e8b65b58fb
https://doi.org/10.1158/2326-6066.22542565.v1
https://doi.org/10.1158/2326-6066.22542565.v1
Autor:
Reshmi Parameswaran, John Letterio, Derek P. Wong, Keman Zhang, Abhishek Asthana, Rose Beck, Hermann Gram, Yorleny Vicioso
Drug-resistant acute lymphoblastic leukemia (ALL) patients do not respond to standard chemotherapy, and an urgent need exists to develop new treatment strategies. Our study exploited the presence of B-cell activating factor receptor (BAFF-R) on the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::654b96f42e026979af28a25de98f39d2
https://doi.org/10.1158/2326-6066.c.6549982.v1
https://doi.org/10.1158/2326-6066.c.6549982.v1
Figure 1S from Combination Therapy for Treating Advanced Drug-Resistant Acute Lymphoblastic Leukemia
Autor:
Reshmi Parameswaran, John Letterio, Derek P. Wong, Keman Zhang, Abhishek Asthana, Rose Beck, Hermann Gram, Yorleny Vicioso
Supp. Fig. 1 ALL sample characteristics. A, Summary data from 11 adults and 5 pediatric ALL patients. Genetic and diagnostic information was provided by clinical pathologist Rose Beck at University Hospitals Medical Center (UHMC). BAFF-R expression w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7568e4f4ac934db157ba945e19c7d959
https://doi.org/10.1158/2326-6066.22542577.v1
https://doi.org/10.1158/2326-6066.22542577.v1
Autor:
Reshmi Parameswaran, John Letterio, Derek P. Wong, Keman Zhang, Abhishek Asthana, Rose Beck, Hermann Gram, Yorleny Vicioso
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8d015857fd705759984f56f9c99c9e2
https://doi.org/10.1158/2326-6066.22542559
https://doi.org/10.1158/2326-6066.22542559
Figure 3S from Combination Therapy for Treating Advanced Drug-Resistant Acute Lymphoblastic Leukemia
Autor:
Reshmi Parameswaran, John Letterio, Derek P. Wong, Keman Zhang, Abhishek Asthana, Rose Beck, Hermann Gram, Yorleny Vicioso
Supp. Fig. 3 Differential NK cells receptor expression A, Expression of activating and inhibitory receptors in NK cells expanded from the indicated healthy donors (mean {plus minus} SD of 3 technical replicates). B, Expression of HLAE and MICA/B on t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49f28c5de113fae2d54ed7a4b4719b9b
https://doi.org/10.1158/2326-6066.22542571.v1
https://doi.org/10.1158/2326-6066.22542571.v1
Figure 2S from Combination Therapy for Treating Advanced Drug-Resistant Acute Lymphoblastic Leukemia
Autor:
Reshmi Parameswaran, John Letterio, Derek P. Wong, Keman Zhang, Abhishek Asthana, Rose Beck, Hermann Gram, Yorleny Vicioso
Supp. Fig. 2 BAFF induces up-regulation of survival pathways. A, PT-3 ALL cells were cultured with VAY736 (20 μg/mL) and recombinant BAFF (0.2 μg/mL) for 72 hours and the expression levels of proliferation genes (p100, p52) and survival
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59a5c5920d5220f6e8b42a47722e848a
https://doi.org/10.1158/2326-6066.22542574.v1
https://doi.org/10.1158/2326-6066.22542574.v1
Figure 4S from Combination Therapy for Treating Advanced Drug-Resistant Acute Lymphoblastic Leukemia
Autor:
Reshmi Parameswaran, John Letterio, Derek P. Wong, Keman Zhang, Abhishek Asthana, Rose Beck, Hermann Gram, Yorleny Vicioso
Supp. Fig. 4 Detection of NK cells in vivo A, Representative Dot plots of gated live cells based on FSCÃ,ÂA and SSCÃ,ÂA and CD19+CD10+ cells in the bone marrow and spleen of NSG mice treated with PBS (left) or 2x106 PTÃ,Â3 ALL cells (righ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11637cc874e8b59dffe0ec97531a4308
https://doi.org/10.1158/2326-6066.22542568.v1
https://doi.org/10.1158/2326-6066.22542568.v1